RxDoctor Payments DataLook up a doctor →

Timothy Grange, MD

Physical Medicine & Rehabilitation · Salt Lake City, UTNPI 1932169430

Payments from drug & device makers

$11,315in general payments, 2019–2025

Across 490 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Boston Scientific$998
  • Medtronic$983
  • Collegium Pharmaceutical, Inc.$848
  • Pfizer$624
  • plus $5K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)92$1,797
Biohaven Pharmaceuticals, Inc.9$1,318
Boston Scientific13$998
Medtronic(2 entities)9$983
Collegium Pharmaceutical, Inc.61$848
Pfizer48$624
Indivior Inc.29$569
Axsome Therapeutics, Inc.17$302
Amgen(2 entities)17$300
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC17$288
Globus Medical10$275
Lundbeck LLC13$232
Scilex Pharmaceuticals Inc.14$230
Merck5$177
Radius Health, Inc.10$169
Biodelivery Sciences International, Inc.11$151
Lilly USA, LLC8$127
Novo Nordisk1$122
Zyla Life Sciences, Inc.16$120
SPR Therapeutics, Inc1$120
Novartis2$118
Teva Pharmaceuticals USA, Inc.6$104
Braeburn Inc.5$94
Jazz Pharmaceuticals Inc.6$92
Idorsia Pharmaceuticals US Inc5$90
Eisai Inc.4$73
Azurity Pharmaceuticals, Inc.5$71
Ipsen Biopharmaceuticals, Inc1$71
Arbor Pharmaceuticals, Inc.5$70
Upsher-smith Laboratories LLC4$67
Almatica Pharma LLC4$66
Biohaven Pharmaceutical Holding Company Ltd.4$63
AstraZeneca4$50
Virtus Pharmaceuticals LLC3$43
Titan Pharmaceuticals, Inc.3$41
Assertio Therapeutics, Inc.3$40
Kaleo, Inc.2$36
Bioventus LLC2$34
GRT US Holding, Inc.2$32
Merz Pharmaceuticals, LLC1$25
Tersera Therapeutics LLC2$24
Biogen1$21
Hikma Pharmaceuticals USA1$21
Abbott1$20
Organogenesis Inc.1$20
Orexo US, Inc.1$18
Vertex1$17
Alfasigma USA, Inc.1$16
Shionogi Inc1$16
Ferring Pharmaceuticals Inc.1$15
Si-bone, Inc.1$15
Johnson & Johnson1$14
Redhill Biopharma Inc.1$14
MDD US Operations, LLC1$13
Supernus Pharmaceuticals, Inc.1$13
Antares Pharma, Inc.1$12
Daiichi Sankyo Inc.1$11

How this compares

$11,315 in reported general payments places this provider in the 90th percentile of 117 physical medicine & rehabilitation providers in Utah.

See all physical medicine & rehabilitation providers in Utah →

Medicare billing

Part B allowed, 2024
$54,949
Medicare patients
129
Services billed
1,149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physical medicine & rehabilitation in Salt Lake City

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →